CuraTeQ Biologics s.r.o.

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2025	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierCuraTeQ Biologics s.r.o.

At-a-glance view of the first 2 buyers in the ranked list below.

NHS England1 award · no published value assigned · 1 values excluded
NHS England1 award · no published value assigned · 1 values excluded

Source records

Published awards

2 records linked to this supplier.

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
Buyer: NHS England
End date in notice
31 Aug 2027
Value shown in notice
£986,282,758Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323 / ocds-b5fd17-04aa1520-7ead-4f1f-bebb-422062580323-1
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
Buyer: NHS England

Published records by year

Buyer relationships by value counted

Published awards

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025